![Sheila Gujrathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Gujrathi
Directeur/Membre du Conseil chez
PROCESSA PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/06/2026
Profil
Sheila Gujrathi est une femme d'affaires qui a fondé Gossamer Bio, Inc. et qui a été à la tête de 5 entreprises différentes. Le Dr. Gujrathi occupe le poste de président de Turning Point Therapeutics, Inc, de président d'ADARx Pharmaceuticals, Inc, de directeur général de GB001, Inc et de directeur général de GB006, Inc. Sheila Gujrathi est également membre du conseil d'administration de Janux Therapeutics, Inc. Dans le passé, elle a été présidente, directrice générale et directrice de Gossamer Bio, Inc, vice-présidente du groupe de développement clinique mondial de Bristol Myers Squibb Co. et directrice médicale de Receptos LLC (une filiale de Bristol Myers Squibb Co.) et chef d'équipe de franchise de Genentech, Inc. Elle a obtenu un doctorat et un diplôme de premier cycle à l'université Northwestern.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,19 % | 15/02/2026 | 112 639 ( 0,19 % ) | 2 M $ | 30/06/2026 |
| 06/08/2026 | 90 160 ( 0,42 % ) | 1 M $ | 30/06/2026 | |
49,61 % | 28/07/2026 | 70 812 ( 49,61 % ) | 135 959 $ | 30/06/2026 |
Postes actifs de Sheila Gujrathi
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/03/2021 |
| PROCESSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/07/2026 |
| BLOSSOMHILL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2026 |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Président | 01/05/2023 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultant / Advisor | - |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Président | 20/01/2022 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Consultant / Advisor | 01/11/2021 |
Anciens postes connus de Sheila Gujrathi
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Président | 04/03/2026 |
| TURG POIN | Président | 30/03/2021 |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sheila Gujrathi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
GB001, Inc.
 GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
GB006, Inc.
 GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
